Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
OTC Markets Group Inc. (OTCM)
New York City, NY, US
OTC Markets Group Inc. is a significant participant in global financial markets, operating both within the United States and internationally. The company provides a comprehensive suite of trading and quotation systems. This includes the OTC Link Alternative Trading System, which serves as an interdealer platform for quotations and trade messaging; OTC Dealer, a real-time, user-facing application offering consolidated quotes, trading capabilities, and market information to enhance liquidity; and OTC FIX, which utilizes the industry-standard FIX protocol for quote submission, trade management, and routing of execution reports. Additionally, OTC Markets Group operates OTC Link Electronic Communication Networks (ECN) and OTC Link National Quotation Bureau (NQB), acting as the executing party on an agency basis for transactions carried out on these platforms. Its extensive data product portfolio features OTC Markets Real-Time Data, supplying current quote, trade, and reference information for the OTC Link ATS. It also encompasses OTC Markets Pricing and Reference Data, providing a detailed view of the securities and issuers within the OTC market, alongside various compliance-focused data solutions. Beyond trading infrastructure, OTC Markets Group offers critical disclosure and communication tools. These include the OTC Disclosure & News Service for disseminating financial reports, news, and other data; Real-Time Level 2 Quote Display, a sponsored service that enables investors to view live Level 2 quotes directly on otcmarkets.com and issuer websites; and the Blue Sky Monitoring Service, which delivers analysis, review, and expert guidance regarding adherence to U.S. securities regulations. Furthermore, the firm orchestrates Virtual Investor Conferences, allowing listed entities to connect and interact with their investor base. The company also manages key market tiers: the premium OTCQX Best Market, the growth-focused OTCQB Venture Market, and the accessible Pink Open Market. Additional services extend to providing software and analytical tools for risk and performance management within the banking and finance sectors, facilitating online capital raising, and managing OTCIQ, an investor relations portal. Originally established in 1904, the company was formerly known as Pink OTC Markets Inc. before officially rebranding as OTC Markets Group Inc. in January 2011. Its corporate headquarters are situated in New York, New York.
4 articles
- Orogen Royalties Inc Begins Trading on OTCQX Best Market GlobeNewsWire
- OTC Markets welcomes Tectonic Metals to OTCQX Best Market Proactive Investors - Finance
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.76% | -0.80% | +1.64% | +1.47% | +2.69% | +6.55% | +9.87% | -7.36% | +30.14% | +225.36% | +1,266.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Financial - Data & Stock Exchanges: +11.9%+19.9% ★ Q1'26: -0.1% (vs Q1'25)
-
EPS growth Financial - Data & Stock Exchanges: +19.9%+14.2% Q1'26: +18.0% (vs Q1'25)
-
FCF margin FCF growth · Financial - Data & Stock Exchanges: +25.6%+31.1% ★ Q1'26: -2.5% (vs Q1'25)
-
EBIT margin Financial - Data & Stock Exchanges: +51.8%+31.5% Q1'26: +28.4% (vs Q1'25)
-
ROIC Financial - Data & Stock Exchanges: +13.5%— Q1'26: +636.0% (vs Q1'25)
-
Share dilution Financial - Data & Stock Exchanges: +0.6%+0.0% Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Financial - Data & Stock Exchanges: -0.36×0.27× ★ Q1'26: 0.23× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
49.91M
est: 47.80M (+4.4%)
|
50.88M
est: 48.55M (+4.8%)
|
54.66M
est: 51.94M (+5.2%)
|
59.28M
est: 57.25M (+3.5%)
|
60.35M
est: 61.37M (-1.7%)
|
68.42M
est: 66.52M (+2.9%)
|
99.91M
est: 93.56M (+6.8%)
|
105.15M
est: 104.50M (+0.6%)
|
109.90M
est: 108.81M (+1.0%)
|
101.23M
est: 104.51M (-3.1%)
|
121.34M
est: 122.50M (-1.0%)
|
129.00M
129.00M – 129.00M
+5.3% YoY
|
133.09M
133.09M – 133.09M
+3.2% YoY
|
| EBITDA |
18.56M
est: 16.93M (+9.6%)
|
18.53M
est: 17.19M (+7.8%)
|
19.67M
est: 18.39M (+6.9%)
|
20.69M
est: 20.28M (+2.0%)
|
19.48M
est: 21.73M (-10.4%)
|
23.20M
est: 23.56M (-1.5%)
|
39.81M
est: 33.13M (+20.2%)
|
38.91M
est: 37.01M (+5.2%)
|
34.99M
est: 38.53M (-9.2%)
|
34.89M
est: 36.95M (-5.6%)
|
40.80M
est: 43.31M (-5.8%)
|
45.61M
45.61M – 45.61M
+5.3% YoY
|
47.06M
47.06M – 47.06M
+3.2% YoY
|
| EBIT |
16.87M
est: 15.86M (+6.4%)
|
16.93M
est: 16.11M (+5.1%)
|
18.30M
est: 17.23M (+6.2%)
|
19.65M
est: 18.99M (+3.4%)
|
17.99M
est: 20.36M (-11.7%)
|
21.41M
est: 22.07M (-3.0%)
|
37.97M
est: 31.04M (+22.3%)
|
36.97M
est: 34.67M (+6.6%)
|
32.59M
est: 36.10M (-9.7%)
|
32.21M
est: 34.71M (-7.2%)
|
38.24M
est: 40.68M (-6.0%)
|
42.84M
42.84M – 42.84M
+5.3% YoY
|
44.20M
44.20M – 44.20M
+3.2% YoY
|
| Net Income |
10.26M
est: 10.51M (-2.4%)
|
10.53M
est: 10.82M (-2.7%)
|
12.56M
est: 12.74M (-1.4%)
|
16.24M
est: 16.17M (+0.4%)
|
14.94M
est: 15.09M (-1.0%)
|
18.27M
est: 16.78M (+8.9%)
|
30.48M
est: 27.70M (+10.0%)
|
30.81M
est: 29.48M (+4.5%)
|
27.66M
est: 27.94M (-1.0%)
|
27.36M
est: 27.90M (-1.9%)
|
31.14M
est: 30.39M (+2.5%)
|
33.88M
33.88M – 33.88M
+11.5% YoY
|
35.78M
35.78M – 35.78M
+5.6% YoY
|
| SGA |
5.40M
est: 7.52M (-28.2%)
|
4.97M
est: 7.64M (-34.9%)
|
5.14M
est: 8.17M (-37.1%)
|
6.39M
est: 9.00M (-29.0%)
|
13.24M
est: 9.65M (+37.1%)
|
13.31M
est: 10.46M (+27.2%)
|
16.78M
est: 14.72M (+14.0%)
|
19.70M
est: 16.44M (+19.9%)
|
13.36M
est: 17.11M (-21.9%)
|
11.64M
est: 14.69M (-20.8%)
|
13.48M
est: 17.22M (-21.8%)
|
18.14M
18.14M – 18.14M
+5.3% YoY
|
18.71M
18.71M – 18.71M
+3.2% YoY
|
| EPS |
0.87
est: 0.89 (-2.0%)
|
0.92
est: 0.91 (+0.7%)
|
1.10
est: 1.08 (+2.2%)
|
1.44
est: 1.37 (+5.5%)
|
1.28
est: 1.27 (+0.4%)
|
1.56
est: 1.42 (+10.1%)
|
2.59
est: 2.34 (+10.7%)
|
2.60
est: 2.49 (+4.4%)
|
2.32
est: 2.36 (-1.7%)
|
2.29
est: 2.36 (-2.8%)
|
2.59
est: 2.57 (+1.0%)
|
2.86
2.86 – 2.86
+11.5% YoY
|
3.02
3.02 – 3.02
+5.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | LAURUS INVESTMENT COUNSEL INC. | 20.0K +— (+0.0%) | 1.07M +44.6K (+4.3%) | 0.17% +0.000 pp | 1.05% +0.213 pp | USD47.45 +12.8% | 5 qtrs — |
| 2 | ISTHMUS PARTNERS, LLC | 12.1K -3.0K (-20.1%) | 645.9K -129.1K (-16.7%) | 0.10% -0.026 pp | 0.07% -0.018 pp | USD39.27 +36.3% | 23 qtrs — |
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Horizon Kinetics Blockchain Development ETF BCDF | 2.24% | 505.8K | 0.85% |
| 2 | Acuitas Small Cap Active ETF AIMS | 0.22% | 165.9K | 0.75% |
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-09 | CLARK CHRISTOPHER D | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-05-10 | MEHLMAN ARTHUR S | Director | P-Purchase | A | Common Stock | 100 | 11.66 | 1.2K | 100 | — | ↗ |
| 2004-05-07 | ROYCE CHARLES M | Director / Officer | S-Sale | D | Common Stock | 17,900 | 12.35 | 221.0K | 855,434 | — | ↗ |
| 2004-05-06 | ROYCE CHARLES M | Director / Officer | S-Sale | A | Common Stock | 1,190 | 12.89 | 15.3K | 873,334 | — | ↗ |
| 2004-05-05 | ROYCE CHARLES M | Director / Officer | S-Sale | D | Common Stock | 200 | 13.34 | 2.7K | 874,524 | — | ↗ |
| 2004-04-15 | MEHLMAN ARTHUR S | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2003-11-07 | ROYCE CHARLES M | Director / Officer | S-Sale | D | Common Stock | 15,000 | 12.52 | 187.8K | 344,656 | — | ↗ |
| 2003-11-06 | ROYCE CHARLES M | Director / Officer | S-Sale | D | Common Stock | 15,000 | 12.37 | 185.6K | 359,656 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael Richard Modeski | President of OTC Link LLC | 976.9K | male |
| Daniel Zinn | Chief of Staff, General Counsel & Corporate Secretary | 822.2K | male |
| Robert Cromwell Coulson | President, Chief Executive Officer & Director | 793.5K | male |
| Jason L. Paltrowitz | Executive Vice President of Corporate Services | 792.9K | male |
| Antonia Georgieva | Chief Financial Officer | 721.5K | female |
| Matthew Fuchs | Executive Vice President of Market Data Licensing | 693.6K | male |
| Lisabeth Heese | Executive Vice President of Issuer & Information Services | 631.1K | female |
| Bruce Ostrover | Chief Technology Officer | 564.0K | male |
| Kristie Harkins | Chief Marketing Officer | — | female |
| Joe Oltmanns | Senior Vice President of Corporate Services - U.S. | — | — |
| John Viglotti | SVP of Corporate Services - Investor Access | — | — |
| Chris King | Senior Vice President of Corporate Services - International | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OTCM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
